1. Home
  2. MYGN vs DNUT Comparison

MYGN vs DNUT Comparison

Compare MYGN & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.75

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Logo Krispy Kreme Inc.

DNUT

Krispy Kreme Inc.

HOLD

Current Price

$3.41

Market Cap

602.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
DNUT
Founded
1991
1937
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Food Chains
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
481.6M
602.2M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
MYGN
DNUT
Price
$4.75
$3.41
Analyst Decision
Buy
Buy
Analyst Count
8
6
Target Price
$7.64
$4.72
AVG Volume (30 Days)
1.6M
1.9M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
1.04%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$771,400,000.00
$1,522,616,000.00
Revenue This Year
$6.89
$0.48
Revenue Next Year
$5.35
$3.33
P/E Ratio
N/A
N/A
Revenue Growth
2.33
N/A
52 Week Low
$3.76
$2.58
52 Week High
$8.63
$5.73

Technical Indicators

Market Signals
Indicator
MYGN
DNUT
Relative Strength Index (RSI) 50.63 50.30
Support Level $4.24 $3.07
Resistance Level $5.69 $3.48
Average True Range (ATR) 0.30 0.19
MACD 0.02 -0.01
Stochastic Oscillator 66.48 36.67

Price Performance

Historical Comparison
MYGN
DNUT

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.

Share on Social Networks: